COMMUNIQUÉS West-GlobeNewswire

Hemispherx To Supply Ampligen for Pancreatic Cancer Patients in Canada Under Special Access Program

26/02/2018 - 14:30

ORLANDO, Fla., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) said it is expanding its partnership with myTomorrows to supply Ampligen® for pancreatic cancer patients in Canada under a [...]

Marrone Bio Innovations and Groundwork BioAg Bio-stacked Microbial Seed Treatments Result in Increased Corn and Soybean Yields for the Second Field Trial Season

26/02/2018 - 14:30

DAVIS, Calif. and MOSHAV MAZOR, Israel, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, [...]

Horizon Blue Cross Blue Shield of New Jersey to Cover Interpace’s Molecular Thyroid Tests

26/02/2018 - 14:30

PARSIPPANY, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

26/02/2018 - 14:10

SOUTH ORANGE, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]

Avid Bioservices Announces Resignation of Chief Financial Officer

26/02/2018 - 14:05

TUSTIN, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a company working to improve patient lives by providing high quality biologics manufacturing services to [...]

Novo Nordisk A/S - Share repurchase programme

26/02/2018 - 14:03

Bagsværd, Denmark, 26 February 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Medtronic Receives FDA Approval for New Arm Indication for Guardian(TM) Sensor 3 - Further Enhancing the MiniMed(TM) 670G Hybrid Closed Loop Experience

26/02/2018 - 14:01

DUBLIN- February 26, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved a new arm indication for the Guardian(TM) [...]

Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older

26/02/2018 - 14:00

DALLAS and FORT WORTH, Texas, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]

Catalyst Biosciences Announces Manufacturing Agreement with AGC Biologics for Subcutaneous Factor IX Product CB 2679d

26/02/2018 - 14:00

Catalyst plans to initiate a Phase 2b study of CB 2679d in Q3 2018 SOUTH SAN FRANCISCO, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company [...]

Vericel to Present at the 13th Annual Canaccord Genuity Musculoskeletal Conference

26/02/2018 - 14:00

CAMBRIDGE, Mass., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]

K2M and International Spine Study Group Foundation Collaborate to Advance Data Management Using BACS®

26/02/2018 - 14:00

LEESBURG, Va., Feb. 26, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Athenex, Inc. to Report Fourth Quarter and Full Year 2017 Earnings Results on March 26, 2018

26/02/2018 - 14:00

BUFFALO, N.Y., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Profound Medical to Participate in 2018 BTIG Healthcare Conference

26/02/2018 - 14:00

TORONTO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to offer a therapeutic platform that provides the precision of real-time MR [...]

ARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical Trial

26/02/2018 - 14:00

-------------------------------------------------------------------------------------------------- Gencaro Demonstrates Comparable Efficacy to Active Control and Trend for Potential Gencaro Superiority in US Patient [...]

Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results

26/02/2018 - 14:00

– Phase 3 VISION Trial Design Finalized for 177 Lu-PSMA-617 Following Successful End of Phase 2 Meeting with the FDA – – Announced Agreement for Clinical Supply of No-Carrier-Added Lutetium with ITM – – Added [...]

Clearside Biomedical Announces Organizational Changes Designed to Support Transition to a Commercial-Stage Company

26/02/2018 - 14:00

ALPHARETTA, Ga., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today [...]

Radient Technologies Inc. Announces Master Services Agreement with Medical Cannabis Supplier Bonify

26/02/2018 - 14:00

EDMONTON, Alberta, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc . ("Radient" or the “Company”) (TSX-V: RTI ) announces the signing of a Master Services Agreement (the “Agreement”) to produce a variety of [...]

Extendicare Announces Agreement to Acquire Lynde Creek Retirement Community

26/02/2018 - 14:00

MARKHAM, Ontario, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced that it has entered into a definitive agreement to acquire the Lynde Creek Retirement [...]

Endocyte and ITM Announce Supply Agreement for No-Carrier-Added Lutetium for the Phase 3 VISION Trial

26/02/2018 - 14:00

WEST LAFAYETTE, Ind. and MUNICH, Germany, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), and ITM Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, today announced a [...]